Neurodiagnostic Platform
Alpha Synuclein
*Parkinson’s, MSA, Alzheimer’s diseases. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.
TDP43
*ALS, FTD, Alzheimer's disease. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.
Tau/pTau
Test/monitor target engagement or off-target effect in the brain. Help *Alzheimer's disease. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.
NF-L
*Brain injury and neuroinflammation. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.
LC3/Cathepsin D
*Autophagy/lysosome across diseases. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.
NF-kB
Biomarker monitoring service to assess biological responses to treatments, including pharmacodynamic and pathway engagement biomarkers.
AKT panel
*Metabolic changes like GLP1. Monitoring biological response to treatments and pharmacodynamic.
Synaptic Protein
*Synaptic plasticity across diseases. Monitoring biological response to treatments and pharmacodynamics.
NeuroDex's Neurodiagnostic Platform
NeuroDex's Neurodiagnostic Platform represents a breakthrough in neurological research, offering comprehensive biomarker panels designed to transform disease detection, treatment monitoring, and therapeutic development. Built on proprietary neuron-derived extracellular vesicle (NDE) technology, the platform delivers unprecedented insights into brain health through minimally invasive testing.
Why Our Neurodiagnostic Platform
Our Neurodiagnostic Platform is a non-invasive, blood-based testing solution that uses neuron-derived exosome biomarkers to detect and monitor neurological diseases. Through a simple blood draw, the platform isolates neuron-derived extracellular vesicles (NDEs). These tiny vesicles cross the blood-brain barrier carrying brain proteins, effectively providing a “liquid biopsy” of the brain neurodex.co. This cutting-edge approach enables identification of key brain biomarkers like alpha-synuclein, tau, and TDP-43 associated with neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and ALS. By delivering precise insights into disease presence and progression, the platform helps clinicians diagnose earlier and track treatment responses with confidence.
Why Choose NeuroDex
At NeuroDex, we are committed to advancing the field of neurological diagnostics through cutting-edge biomarker discovery and innovative testing solutions. Our proprietary technologies and research capabilities enable us to deliver precise and reliable insights for early disease detection, monitoring treatment efficacy, and advancing therapeutic research.
Comprehensive Biomarker Portfolio
The panel targets major neurological conditions with alpha-synuclein for Parkinson's and Alzheimer's, TDP43 for ALS and frontotemporal dementia, Tau/pTau for Alzheimer's monitoring, NF-L for brain injury and neuroinflammation, and LC3/Cathepsin D for autophagy tracking.
Advanced Research Capabilities
NeuroDex offers NF-kB pathway monitoring, AKT metabolic panels, synaptic protein analysis, and RNA sequencing with proteomic analysis of NDEs, plus in-vitro drug response biomarker discovery for accelerated pharmaceutical research.
Advanced Research Capabilities
NeuroDex offers NF-kB pathway monitoring, AKT metabolic panels, synaptic protein analysis, and RNA sequencing with proteomic analysis of NDEs, plus in-vitro drug response biomarker discovery for accelerated pharmaceutical research.
Operational Excellence
NeuroDex's operational excellence is built on rigorous quality standards, including GLP and CLIA compliance, ensuring reliable, reproducible, and high-quality biomarker analysis.
Personalized Insights
NeuroDex's personalized insights approach delivers customized biomarker panels designed to precisely detect and monitor disease markers, supporting targeted research and improved patient outcomes.
Scientific Precision
NeuroDex's scientific precision is driven by advanced isolation and detection techniques that ensure accurate biomarker identification, supporting reliable diagnostics and robust research outcomes.
Collaborative Approach
NeuroDex's collaborative approach involves partnering with clinical and research teams to develop tailored biomarker solutions, fostering seamless integration and impactful research outcomes.
Biomarker Discovery Solutions
NeuroDex provides advanced biomarker discovery solutions that integrate seamlessly into clinical workflows. Our neuron-derived extracellular vesicle (NDE) panels enable precise disease detection, monitoring, and treatment evaluation. Validated under GLP and CLIA standards, our solutions support personalized diagnostics, enhance patient care, and optimize therapeutic strategies.
